Cite
Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy.
MLA
Yan, Chi, and Ann Richmond. “Hiding in the Dark: Pan-Cancer Characterization of Expression and Clinical Relevance of CD40 to Immune Checkpoint Blockade Therapy.” Molecular Cancer, vol. 20, no. 1, Nov. 2021, p. 146. EBSCOhost, https://doi.org/10.1186/s12943-021-01442-3.
APA
Yan, C., & Richmond, A. (2021). Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy. Molecular Cancer, 20(1), 146. https://doi.org/10.1186/s12943-021-01442-3
Chicago
Yan, Chi, and Ann Richmond. 2021. “Hiding in the Dark: Pan-Cancer Characterization of Expression and Clinical Relevance of CD40 to Immune Checkpoint Blockade Therapy.” Molecular Cancer 20 (1): 146. doi:10.1186/s12943-021-01442-3.